Effect of sulpiride on menopausal hot flashes: a randomized, double-blind, placebo-controlled clinical trial
- 3 September 2019
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 36 (3) , 247-251
Abstract
Low doses of sulpiride have been used off-label to treat menopausal hot slashes in Southern Brazil despite limited scientific evidence. This randomized controlled trial aimed at assessing the effects of sulpiride as compared to placebo on the frequency and severity of hot flashes. Postmenopausal women, aged 47–62, were recruited from the Menopause Clinic at Hospital de Clínicas de Porto Alegre, Rio Grande do Sul, Brazil, between March 2016 and January 2017. After a baseline assessment of 4 weeks, women were included if they had at least a mean of five moderate to severe hot flashes per day and then randomized to receive for 8 weeks either placebo (n= 14) or sulpiride 50 mg/d (n= 14). The number and severity of hot flashes were evaluated after the 8-week intervention. A generalized estimating equations (GEE) model with Bonferroni correction was used to simultaneously assess the frequency and severity of hot flashes. Baseline frequency and severity of hot flashes/day were similar in both groups. Sulpiride significantly reduced the total weekly mean of hot flash frequency (GEE, pinteraction=.019) and the total weekly mean of severity scores (GEE, pinteraction=.09, pgroup=.006, ptime≤.0001) after 4 and 8 weeks of treatment. Treatment with sulpiride 50 mg/d significantly reduced the frequency and severity of hot flashes. Further studies are needed to confirm its benefits and related mechanisms of action.Keywords
This publication has 26 references indexed in Scilit:
- Safety of veralipride for the treatment of vasomotor symptoms of menopauseMenopause, 2014
- The kisspeptin-GnRH pathway in human reproductive health and diseaseHuman Reproduction Update, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: A novel hypothesis on the mechanism of hot flushesFrontiers in Neuroendocrinology, 2013
- Effect of escitalopram on hot flash interference: a randomized, controlled trialFertility and Sterility, 2012
- CONSORT 2010 StatementObstetrics & Gynecology, 2010
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivoPsychopharmacology, 2009
- Nonhormonal Therapies for Menopausal Hot FlashesJAMA, 2006
- The treatment of acute vertigoNeurological Sciences, 2004
- Paroxetine Controlled Release in the Treatment of Menopausal Hot FlashesJAMA, 2003